DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
Abstract Triplet DCF (docetaxel, cisplatin and 5-flurouracil) and doublet CP/CF (carboplatin and paclitaxel/cisplatin and 5-fluorouracil) regimens were prospectively evaluated in advanced squamous anal cell carcinoma (SCCA), and validated as standard treatments. Even though the high efficacy and goo...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2023-07-01
|
| Serier: | Experimental Hematology & Oncology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s40164-023-00413-2 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
